المؤلفون: Alexis Ogdie, Joseph F. Merola, Philip J. Mease, Christopher T. Ritchlin, Jose U. Scher, Kimberly Parnell Lafferty, Daphne Chan, Soumya D. Chakravarty, Wayne Langholff, Yanli Wang, Olivia Choi, Yevgeniy Krol, Alice B. Gottlieb

المصدر: BMC Rheumatology, Vol 8, Iss 1, Pp 1-12 (2024)

مصطلحات موضوعية: Psoriatic arthritis, TNFi-IR, Randomized controlled trial, Guselkumab, IL-23p19, Diseases of the musculoskeletal system, RC925-935

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2520-1026Test

الوصول الحر: https://doaj.org/article/8af8899c7fd64bf9a16ff7465d160dd3Test

المؤلفون: Beck, Kristen M, Sanchez, Isabelle M, Yang, Eric J, Liao, Wilson

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Immunology, Immunization, Autoimmune Disease, Psoriasis, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Inflammatory and immune system, Skin, tildrakizumab, IL-23, IL-23p19, biologics, psoriasis

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/33n7k6c5Test

المؤلفون: Mai Nishimura, Makoto Kondo, Koji Habe, Akinobu Hayashi, Keiichi Yamanaka

المصدر: Clinical Case Reports, Vol 10, Iss 10, Pp n/a-n/a (2022)

مصطلحات موضوعية: cyclosporine, guselkumab, IL‐23p19, pityriasis rubra pilaris, Medicine, Medicine (General), R5-920

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2050-0904Test

الوصول الحر: https://doaj.org/article/31486632d3734a3c9d07b679182c5194Test

المؤلفون: Lucie Van Esbeen, MD, Pierre-Paul Roquet-Gravy, MD

المصدر: JAAD Case Reports, Vol 17, Iss , Pp 84-86 (2021)

مصطلحات موضوعية: angiosarcoma, case report, guselkumab, IL-23p19, Stewart-Treves, treatment, Dermatology, RL1-803

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2352512621006974Test; https://doaj.org/toc/2352-5126Test

الوصول الحر: https://doaj.org/article/1b3f7f3254d44d6eaaa003d54a42d74eTest

المؤلفون: Jiang, Xin-Xin, Tang, Zi-Rui, Li, Zhang-Ping, Zhang, Gui-Rong, Zhou, Xu, Ma, Xu-Fa, Wei, Kai-Jian

المصدر: Fish Shellfish Immunol ; ISSN:1095-9947 ; Volume:150

مصطلحات موضوعية: Expression patterns, IL-12p35a/b, IL-12p40a/b/c, IL-23p19, Pelteobagrus fulvidraco

العلاقة: https://doi.org/10.1016/j.fsi.2024.109623Test; https://pubmed.ncbi.nlm.nih.gov/38750705Test

الإتاحة: https://doi.org/10.1016/j.fsi.2024.109623Test
https://pubmed.ncbi.nlm.nih.gov/38750705Test

المؤلفون: Näslund-Koch C, Zachariae C, Skov L

المصدر: Therapeutics and Clinical Risk Management, Vol Volume 16, Pp 903-916 (2020)

مصطلحات موضوعية: tildrakizumab, il-23p19, biologics, psoriasis, safety, efficacy, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/tildrakizumab-an-evidence-based-review-of-its-use-in-the-treatment-of--peer-reviewed-article-TCRMTest; https://doaj.org/toc/1178-203XTest

الوصول الحر: https://doaj.org/article/50580742ac354a1680217e87fab4c27bTest

المؤلفون: Gladman, DD, Mease, PJ, Bird, P, Soriano, ER, Chakravarty, SD, Shawi, M, Xu, S, Quinn, ST, Gong, C, Leibowitz, E, Poddubnyy, D, Tam, LS, Helliwell, PS, Kavanaugh, A, Deodhar, A, Østergaard, M, Baraliakos, X

المصدر: urn:ISSN:1468-6708 ; urn:ISSN:1745-6215 ; Trials, 23, 1, 743

مصطلحات موضوعية: Clinical Trials and Supportive Activities, Complementary and Integrative Health, Autoimmune Disease, Arthritis, Clinical Research, 6 Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Musculoskeletal, Inflammatory and immune system, Antibodies, Monoclonal, Humanized, Psoriatic, C-Reactive Protein, Clinical Trials, Phase IV as Topic, Double-Blind Method, Humans, Inflammation, Randomized Controlled Trials as Topic, Spondylarthritis, Spondylitis, Ankylosing, Treatment Outcome, Axial psoriatic arthritis, Guselkumab, IL-23p19, MRI, Psoriatic arthritis, Randomized controlled trial

وصف الملف: application/pdf

العلاقة: http://hdl.handle.net/1959.4/unsworks_84454Test; https://unsworks.unsw.edu.au/bitstreams/a44d0875-2fa8-4bab-aa89-9505012ff6aa/downloadTest; https://doi.org/10.1186/s13063-022-06589-yTest

الإتاحة: https://doi.org/10.1186/s13063-022-06589-yTest
http://hdl.handle.net/1959.4/unsworks_84454Test
https://unsworks.unsw.edu.au/bitstreams/a44d0875-2fa8-4bab-aa89-9505012ff6aa/downloadTest

المؤلفون: Beck KM, Sanchez IM, Yang EJ, Liao W

المصدر: Psoriasis: Targets and Therapy, Vol Volume 8, Pp 49-58 (2018)

مصطلحات موضوعية: tildrakizumab, IL-23, IL-23p19, biologics, psoriasis, Dermatology, RL1-803

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/profile-of-tildrakizumab-asmn-in-the-treatment-of-moderate-to-severe-p-peer-reviewed-article-PTTTest; https://doaj.org/toc/2230-326XTest

الوصول الحر: https://doaj.org/article/cbdbae5932784b5585b125fc06cef0a8Test

المؤلفون: Näslund-Koch, Charlotte, Zachariae, Claus, Skov, Lone

المصدر: Näslund-Koch , C , Zachariae , C & Skov , L 2020 , ' Tildrakizumab : An evidence-based review of its use in the treatment of moderate-to-severe chronic plaque psoriasis ' , Therapeutics and Clinical Risk Management , vol. 16 , pp. 889-901 . https://doi.org/10.2147/TCRM.S258704Test

مصطلحات موضوعية: Biologics, Efficacy, IL-23p19, Psoriasis, Safety, Tildrakizumab

وصف الملف: application/pdf

الإتاحة: https://doi.org/10.2147/TCRM.S258704Test
https://curis.ku.dk/portal/da/publications/tildrakizumabTest(580284f8-4263-4414-bace-5de687c8af80).html
https://curis.ku.dk/ws/files/255842320/tcrm_227880_tildrakizumab_an_evidence_based_review_of_its_use_in_the_tr.pdfTest

المؤلفون: Dafna D. Gladman, Philip J. Mease, Paul Bird, Enrique R. Soriano, Soumya D. Chakravarty, May Shawi, Stephen Xu, Sean T. Quinn, Cinty Gong, Evan Leibowitz, Denis Poddubnyy, Lai-Shan Tam, Philip S. Helliwell, Arthur Kavanaugh, Atul Deodhar, Mikkel Østergaard, Xenofon Baraliakos

المصدر: Gladman, D D, Mease, P J, Bird, P, Soriano, E R, Chakravarty, S D, Shawi, M, Xu, S, Quinn, S T, Gong, C, Leibowitz, E, Poddubnyy, D, Tam, L S, Helliwell, P S, Kavanaugh, A, Deodhar, A, Østergaard, M & Baraliakos, X 2022, ' Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis : study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial ', Trials, vol. 23, 743 . https://doi.org/10.1186/s13063-022-06589-yTest

مصطلحات موضوعية: Inflammation, Guselkumab, Arthritis, Psoriatic, Medicine (miscellaneous), Axial psoriatic arthritis, Sacroiliac joint, Clinical Trials, Phase IV as Topic, Antibodies, Monoclonal, Humanized, IL-23p19, C-Reactive Protein, Treatment Outcome, Double-Blind Method, Randomized controlled trial, Psoriatic arthritis, Spondylarthritis, Humans, Spondylitis, Ankylosing, Pharmacology (medical), Spine inflammation, MRI, Randomized Controlled Trials as Topic

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba88bda62e553ef9488f13aed1f5ca03Test
https://doi.org/10.1186/s13063-022-06589-yTest